Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,013 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $380.37 | 5 | $0 (2024) |
| AbbVie Inc. | $124.57 | 1 | $0 (2021) |
| PharmaEssentia USA Corporation | $122.47 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $118.00 | 1 | $0 (2023) |
| Fisher & Paykel Healthcare Limited | $105.00 | 1 | $0 (2021) |
| Fresenius Kabi USA, LLC | $99.90 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $41.62 | 2 | $0 (2023) |
| La Jolla Pharmaceutical Company | $21.32 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.46 | 1 | Heron Therapeutics, Inc. ($46.46) |
| 2023 | $413.01 | 6 | Heron Therapeutics, Inc. ($253.39) |
| 2022 | $202.99 | 2 | PharmaEssentia USA Corporation ($122.47) |
| 2021 | $329.47 | 3 | AbbVie Inc. ($124.57) |
| 2019 | $21.32 | 1 | La Jolla Pharmaceutical Company ($21.32) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | Heron Therapeutics, Inc. | APONVIE (Drug), ZYNRELEF | Food and Beverage | Cash or cash equivalent | $46.46 | General |
| Category: NAUSEAVOMITING | ||||||
| 12/09/2023 | Heron Therapeutics, Inc. | APONVIE (Drug) | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| Category: NAUSEAVOMITING | ||||||
| 11/29/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | Cash or cash equivalent | $75.23 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 04/13/2023 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | Cash or cash equivalent | $118.16 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 10/07/2022 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $122.47 | General |
| Category: Oncology | ||||||
| 04/01/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $80.52 | General |
| Category: Postoperative Pain | ||||||
| 12/12/2021 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $99.90 | General |
| 12/11/2021 | Fisher & Paykel Healthcare Limited | Optiflow Anesthesia Kit (Device), Optiflow THRIVE Anesthesia Filtered Cannula Medium | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: Anesthesia | ||||||
| 11/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: GIAPREZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 111 | 155 | $39,894 | $7,212 |
| 2022 | 3 | 116 | 175 | $44,077 | $6,892 |
| 2021 | 3 | 109 | 144 | $27,543 | $5,129 |
| 2020 | 3 | 55 | 74 | $15,850 | $4,042 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 65 | 105 | $15,645 | $4,954 | 31.7% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2023 | 25 | 29 | $21,750 | $1,670 | 7.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 21 | 21 | $2,499 | $588.21 | 23.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 56 | 102 | $15,198 | $3,786 | 24.9% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2022 | 19 | 32 | $24,000 | $1,922 | 8.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 41 | 41 | $4,879 | $1,183 | 24.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 48 | 75 | $11,129 | $2,696 | 24.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 49 | 56 | $6,664 | $1,643 | 24.6% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2021 | 12 | 13 | $9,750 | $790.27 | 8.1% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 13 | 13 | $7,241 | $1,906 | 26.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 45 | $6,705 | $1,663 | 24.8% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2020 | 16 | 16 | $1,904 | $472.72 | 24.8% |
About Dr. Jeff Xu, MD
Dr. Jeff Xu, MD is a Anesthesiology healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316191208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeff Xu, MD has received a total of $1,013 in payments from pharmaceutical and medical device companies, with $46.46 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,013).
As a Medicare-enrolled provider, Xu has provided services to 391 Medicare beneficiaries, totaling 548 services with total Medicare billing of $23,274. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology
- Location Valhalla, NY
- Active Since 11/05/2008
- Last Updated 12/18/2020
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1316191208
Products in Payments
- ZYNRELEF (Drug) $193.39
- UBRELVY (Drug) $124.57
- BESREMI (Drug) $122.47
- IMFINZI (Biological) $118.00
- APONVIE (Drug) $106.46
- Optiflow Anesthesia Kit (Device) $105.00
- Zynrelef (Drug) $80.52
- BRIDION (Drug) $41.62
- GIAPREZA (Drug) $21.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Valhalla
Ammar Siddiqui, M.d, M.D
Anesthesiology — Payments: $2,108
Dr. Toni Manougian, M.d, M.D
Anesthesiology — Payments: $1,329
Sangeeta Kumaraswami, M.d, M.D
Anesthesiology — Payments: $1,244
Dr. Saman Yaghoubian, D.o, D.O
Anesthesiology — Payments: $1,172
Suryanarayana Pothula, M.d, M.D
Anesthesiology — Payments: $1,139
Dr. Joey Mancuso, D.o, D.O
Anesthesiology — Payments: $1,106